BRCA2 and pachyonychia congenita: As was known that gemcitabine was a chemotherapy agent for multiple malignancies including PC, and during the progress where DNA replication arrest was converted into double-strand break induced by gemcitabine, BRCA2 was recruited to inhibit DNA replication and damage repair, which further promoted gemcitabine cytotoxicity and ultimately led to cell death [124].